Found: 21
Select item for more details and to access through your institution.
Discovery and characterization of a small‐molecule enteropeptidase inhibitor, SCO‐792.
- Published in:
- Pharmacology Research & Perspectives, 2019, v. 7, n. 5, p. 1, doi. 10.1002/prp2.517
- By:
- Publication type:
- Article
Enteropeptidase inhibitor SCO-792 effectively prevents kidney function decline and fibrosis in a rat model of chronic kidney disease.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 4, p. 631, doi. 10.1093/ndt/gfaa349
- By:
- Publication type:
- Article
GLP‐1 suppresses glucagon secretion in human pancreatic alpha‐cells by inhibition of P/Q‐type Ca<sup>2+</sup> channels.
- Published in:
- Physiological Reports, 2018, v. 6, n. 17, p. 1, doi. 10.14814/phy2.13852
- By:
- Publication type:
- Article
The enzymatic activity of inositol hexakisphosphate kinase controls circulating phosphate in mammals.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24934-8
- By:
- Publication type:
- Article
Inositol Hexakisphosphate Kinase 3 Regulates Metabolism and Lifespan in Mice.
- Published in:
- Scientific Reports, 2016, p. 32072, doi. 10.1038/srep32072
- By:
- Publication type:
- Article
Enteropeptidase inhibition improves kidney function in a rat model of diabetic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 86, doi. 10.1111/dom.14190
- By:
- Publication type:
- Article
SCO‐792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2228, doi. 10.1111/dom.13799
- By:
- Publication type:
- Article
Age-dependent telomere-shortening is repressed by phosphorylated α-tocopherol together with cellular longevity and intracellular oxidative-stress reduction in human brain microvascular endotheliocytes.
- Published in:
- Journal of Cellular Biochemistry, 2007, v. 102, n. 3, p. 689, doi. 10.1002/jcb.21322
- By:
- Publication type:
- Article
GPR40 full agonism exerts feeding suppression and weight loss through afferent vagal nerve.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0222653
- By:
- Publication type:
- Article
Identification of a novel small‐molecule allosteric inhibitor of glucose transporter type 5 for treating fructose‐induced diseases.
- Published in:
- FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.00470
- By:
- Publication type:
- Article
Oral SSTR5 Antagonist SCO‐240 for Growth Hormone Stimulation: A Phase I Single‐Dose Study in Healthy Individuals.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 6, p. 1326, doi. 10.1002/cpt.3212
- By:
- Publication type:
- Article
Effects of Combination Treatment with Alogliptin (SYR-322), a Novel Dipeptidyl Peptidase-IV Inhibitor, and Pioglitazone on Glycemic Control in ob/ob Mice.
- Published in:
- Diabetes, 2007, v. 56, p. A545
- By:
- Publication type:
- Article
A Novel Dipeptidyl Peptidase-IV Inhibitor, Alogliptin (SYR-322), Is Effective in a New Rat Model of Sulfonylurea-Induced Secondary Failure.
- Published in:
- Diabetes, 2007, v. 56, p. A545
- By:
- Publication type:
- Article
Chronic Administration of Alogliptin (SYR-322), a Novel Dipeptidyl Peptidase-IV Inhibitor, Improved Beta-Cell Function in ob/ob Mice.
- Published in:
- Diabetes, 2007, v. 56, p. A136
- By:
- Publication type:
- Article
Analysis of insulin-producing cells during in vitro differentiation from feeder-free embryonic stem cells.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Erratum. SCO-267, a GPR40 Full Agonist, Stimulates Islet and Gut Hormone Secretion and Improves Glycemic Control in Humans. Diabetes 2021;70:2364–2376.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
SCO-267, a GPR40 Full Agonist, Stimulates Islet and Gut Hormone Secretion and Improves Glycemic Control in Humans.
- Published in:
- 2021
- By:
- Publication type:
- journal article
751-P: First-in-Human, Single and Repeated Dose Study of SCO-267, a GPR40 Full Agonist, in Healthy Adults and Subjects with Glucose Intolerance.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-751-P
- By:
- Publication type:
- Article
1161-P: SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control More Than That by Fasiglifam in Rat Models of Diabetes and Obesity.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1161-P
- By:
- Publication type:
- Article
Nuclear hormone retinoid X receptor (RXR) negatively regulates the glucose-stimulated insulin secretion of pancreatic ß-cells.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Nuclear Hormone Retinoid X Receptor (RXR) Negatively Regulates the Glucose-Stimulated Insulin Secretion of Pancreatic β-cells.
- Published in:
- Diabetes, 2010, v. 59, n. 11, p. 2854, doi. 10.2337/db09-1897
- By:
- Publication type:
- Article